Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Claryx has raised $3.5 million in pre-seed funding led by Outlander VC to enhance hospital infection controls.
PRIVATEAug 04, 2026•5 days ago
Amount Raised
$3.5 Million
Round Type
Seed
Investors
Outlander Vc
Description
Claryx, a genomic intelligence company, has secured $3.5 million in pre-seed funding. The funding round was led by Outlander VC. The company's mission is to develop an immune system for hospitals that prevents outbreaks. Claryx aims to catch transmission while it occurs and ensure effective intervention.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers